跳至主要内容
临床试验/ITMCTR2100005121
ITMCTR2100005121尚未招募2 期

Clinical study of Rongqingbaohuashuan powder on patients with carotid atherosclerosis

Qilu Hospital of Shandong University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 65(—)
性别
All

入选标准

  • 1. Sign the informed consent form and be aged 40 to 65 years on the day;
  • 2. Fasting low-density lipoprotein cholesterol (LDL-C) >=3.4mmol/L;
  • 3. Fasting triglyceride <=5.6 mmol/L during screening;
  • 4. Carotid ultrasound showed carotid atherosclerotic plaque.

排除标准

  • 1. Those who are allergic to any ingredient in statin or Rongqingbaohua suppository powder food;
  • 2. Those with a history of hypertension and diabetes and a definite diagnosis;
  • 3. Rheumatic immune diseases, malignant tumors, etc.;
  • 4. Various acute and chronic infectious diseases and acute metabolic disorders;
  • 5. Chronic bronchitis, chronic obstructive pulmonary disease, etc.;
  • 6. Liver function alanine aminotransferase (ALT) or aspartate aminotransferase (AST) or total bilirubin is higher than the upper limit of normal;
  • 7. Creatine kinase (CK) is higher than the upper limit of normal;
  • 8. Estimated glomerular filtration rate (eGFR) <= 90ml/min/1.73m2 (calculated by MDRD formula);
  • 9. Those who are currently taking various lipid-lowering drugs (including Western medicines, Chinese patent medicines and other drugs and health care products with lipid-lowering effects).

研究者

相似试验